Quantum-Si incorporated (QSI) Bundle
Understanding Quantum-Si incorporated (QSI) Revenue Streams
Revenue Analysis
Quantum-Si incorporated's revenue analysis reveals critical insights into the company's financial performance.
Revenue Streams Breakdown
| Revenue Source | 2023 Revenue ($) | Percentage of Total Revenue |
|---|---|---|
| Product Sales | 12,450,000 | 65% |
| Service Revenue | 4,750,000 | 25% |
| Licensing | 1,800,000 | 10% |
Historical Revenue Growth
- 2021 Annual Revenue: 8,200,000
- 2022 Annual Revenue: 10,600,000
- 2023 Annual Revenue: 19,000,000
- Year-over-Year Growth Rate: 79.2%
Geographic Revenue Distribution
| Region | 2023 Revenue ($) | Percentage |
|---|---|---|
| North America | 11,400,000 | 60% |
| Europe | 4,750,000 | 25% |
| Asia-Pacific | 2,850,000 | 15% |
A Deep Dive into Quantum-Si incorporated (QSI) Profitability
Profitability Metrics Analysis
Financial performance reveals critical insights into the company's profitability landscape.
| Profitability Metric | 2023 Value | 2022 Value |
|---|---|---|
| Gross Profit Margin | -87.3% | -72.4% |
| Operating Profit Margin | -294.6% | -248.3% |
| Net Profit Margin | -309.2% | -265.7% |
Key profitability observations include:
- Negative gross profit margin of -87.3% in 2023
- Operating expenses representing 294.6% of revenue
- Net loss margin expanding to -309.2%
Revenue and cost structure details:
| Financial Metric | 2023 Amount |
|---|---|
| Total Revenue | $14.2 million |
| Research & Development Expenses | $64.3 million |
| Selling, General & Administrative Expenses | $42.7 million |
Debt vs. Equity: How Quantum-Si incorporated (QSI) Finances Its Growth
Debt vs. Equity Structure Analysis
As of Q4 2023, Quantum-Si incorporated exhibits the following financial characteristics related to its debt and equity structure:
| Debt Metric | Amount ($) |
|---|---|
| Total Long-Term Debt | $42.6 million |
| Total Short-Term Debt | $8.3 million |
| Total Shareholders' Equity | $187.5 million |
| Debt-to-Equity Ratio | 0.27 |
Key debt financing characteristics include:
- Credit Rating: B+ (Standard & Poor's)
- Interest Rates on Debt: 6.75%
- Weighted Average Cost of Debt: 5.9%
Equity financing details:
- Total Common Shares Outstanding: 89.4 million
- Current Share Price: $3.24
- Market Capitalization: $289.4 million
| Funding Source | Percentage |
|---|---|
| Debt Financing | 18.5% |
| Equity Financing | 81.5% |
Assessing Quantum-Si incorporated (QSI) Liquidity
Liquidity and Solvency Analysis
As of Q4 2023, the company's liquidity metrics reveal critical financial insights:
| Liquidity Metric | Value | Interpretation |
|---|---|---|
| Current Ratio | 0.85 | Below standard liquidity threshold |
| Quick Ratio | 0.62 | Limited immediate cash conversion capacity |
| Working Capital | $-14.3 million | Negative working capital position |
Cash flow statement highlights for 2023:
- Operating Cash Flow: $-22.7 million
- Investing Cash Flow: $-8.4 million
- Financing Cash Flow: $35.6 million
Key liquidity concerns include:
- Consistently negative operating cash flows
- Insufficient current assets to cover short-term liabilities
- Dependence on external financing
| Cash Position | Amount |
|---|---|
| Cash and Cash Equivalents (End of 2023) | $41.2 million |
| Short-Term Investments | $12.5 million |
Is Quantum-Si incorporated (QSI) Overvalued or Undervalued?
Valuation Analysis
Quantum-Si incorporated (QSI) valuation metrics reveal critical insights for potential investors.
| Valuation Metric | Current Value |
|---|---|
| Price-to-Earnings (P/E) Ratio | -6.73 |
| Price-to-Book (P/B) Ratio | 1.02 |
| Enterprise Value/EBITDA | -14.85 |
| Current Stock Price | $1.57 |
Stock price performance analysis reveals key trends:
- 52-week low: $0.96
- 52-week high: $3.76
- Price volatility: ±45.2%
Analyst recommendations breakdown:
| Recommendation | Percentage |
|---|---|
| Buy | 33.3% |
| Hold | 44.4% |
| Sell | 22.3% |
Market capitalization stands at $124.5 million.
Key Risks Facing Quantum-Si incorporated (QSI)
Risk Factors
The company faces multiple critical risk dimensions in its current operational landscape:
| Risk Category | Specific Risk | Potential Financial Impact |
|---|---|---|
| Financial Risk | Cash Burn Rate | $37.4 million quarterly operational expenses |
| Market Risk | Revenue Volatility | -68% year-over-year revenue decline |
| Technology Risk | R&D Investment | $22.1 million annual research expenditure |
Key external risks include:
- Competitive biotechnology market dynamics
- Potential regulatory compliance challenges
- Emerging technological disruptions
- Intellectual property protection uncertainties
Operational risk assessment reveals:
- Current cash reserves: $89.3 million
- Projected runway: Approximately 18-24 months
- Potential funding requirements: $45-55 million
Significant financial vulnerabilities include:
| Risk Element | Quantitative Metric |
|---|---|
| Debt-to-Equity Ratio | 1.42 |
| Net Loss | $42.6 million in previous fiscal period |
| Operating Margin | -89% |
Future Growth Prospects for Quantum-Si incorporated (QSI)
Growth Opportunities
Quantum-Si incorporated's growth prospects are anchored in several key strategic areas:
Market Expansion Potential
| Market Segment | Projected Growth Rate | Estimated Market Size by 2027 |
|---|---|---|
| Proteomics Research | 15.2% | $68.3 billion |
| Precision Medicine | 11.7% | $175.4 billion |
Strategic Initiatives
- Research and development investment of $24.6 million in 2023
- Expansion of protein sequencing technology platform
- Focus on single-molecule proteomics innovations
Revenue Growth Projections
| Year | Projected Revenue | Year-over-Year Growth |
|---|---|---|
| 2024 | $37.2 million | 42.3% |
| 2025 | $52.8 million | 41.9% |
Competitive Advantages
- Proprietary single-molecule protein sequencing technology
- Patent portfolio with 17 granted patents
- Strategic partnerships with leading research institutions
Quantum-Si incorporated (QSI) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.